RWP
CVS icon

Revolve Wealth Partners’s CVS Health CVS Stock Holding History

Revolve Wealth Partners’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$734K Buy
7,093
+3,973
+127% +$355K 0.08% 145
2026
Q1 		$224K Sell
3,120
-75
-2% -$5.78K 0.03% 209
2025
Q4 		$254K Sell
3,195
-185
-5% -$14.6K 0.03% 197
2025
Q3 		$255K Buy
3,380
+442
+15% +$30.3K 0.03% 194
2025
Q2 		$203K Buy
+2,938
New +$193K 0.03% 218
2024
Q2 		– Sell
-3,033
Closed -$242K – 182
2024
Q1 		$242K Buy
3,033
+10
+0.3% +$764 0.04% 158
2023
Q4 		$239K Sell
3,023
-579
-16% -$41.2K 0.05% 141
2023
Q3 		$251K Sell
3,602
-162
-4% -$11.5K 0.06% 128
2023
Q2 		$260K Buy
3,764
+424
+13% +$30.2K 0.06% 120
2023
Q1 		$248K Sell
3,340
-1,202
-26% -$101K 0.06% 124
2022
Q4 		$423K Sell
4,542
-637
-12% -$61.5K 0.12% 87
2022
Q3 		$494K Buy
5,179
+984
+23% +$97.4K 0.17% 71
2022
Q2 		$389K Sell
4,195
-133
-3% -$13K 0.13% 81
2022
Q1 		$438K Buy
4,328
+119
+3% +$12.5K 0.13% 81
2021
Q4 		$434K Buy
+4,209
New +$389K 0.12% 86

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Revolve Wealth Partners's CVS Position: Q2 2026 in Review

Revolve Wealth Partners increased its CVS Health (CVS) stake by 127% in Q2 2026, buying an estimated $355K and bringing the position to 7,093 shares worth $734K. The position accounts for 0.08% of the portfolio, ranked #145.

Revolve Wealth Partners first reported a position in CVS in Q4 2021 and has held it in 15 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Revolve Wealth Partners held 7,093 shares of CVS Health worth $734K as of Q2 2026.
  • Revolve Wealth Partners bought 3,973 CVS Health shares in Q2 2026, an estimated $355K.
  • CVS Health made up 0.08% of Revolve Wealth Partners's portfolio in Q2 2026, its #145 holding.
  • Revolve Wealth Partners first reported a position in CVS Health in Q4 2021 and has held it in 15 quarters since.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Revolve Wealth Partners's 13F filing for Q2 2026, filed 9 Jul 2026.